Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) EBIT Margin (2018 - 2025)

Historic EBIT Margin for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 24.71%.

  • Nexgel's EBIT Margin rose 20900.0% to 24.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.54%, marking a year-over-year increase of 329000.0%. This contributed to the annual value of 40.91% for FY2024, which is 441300.0% up from last year.
  • Latest data reveals that Nexgel reported EBIT Margin of 24.71% as of Q3 2025, which was up 20900.0% from 22.05% recorded in Q2 2025.
  • Nexgel's EBIT Margin's 5-year high stood at 22.05% during Q2 2025, with a 5-year trough of 205.05% in Q1 2022.
  • Its 5-year average for EBIT Margin is 101.83%, with a median of 92.93% in 2024.
  • As far as peak fluctuations go, Nexgel's EBIT Margin surged by 5028900bps in 2021, and later crashed by -102900bps in 2022.
  • Nexgel's EBIT Margin (Quarter) stood at 166.42% in 2021, then fell by -10bps to 182.57% in 2022, then soared by 38bps to 112.66% in 2023, then surged by 75bps to 27.66% in 2024, then rose by 11bps to 24.71% in 2025.
  • Its EBIT Margin stands at 24.71% for Q3 2025, versus 22.05% for Q2 2025 and 27.69% for Q1 2025.